Small-Molecule Neutrophil Modulator ADS051 is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.
Cheifetz, Adam S, Jessica R Allegretti, Megan Quintas, Bharat Dixit, Ronald Farquhar, Benjamin W Miller, Christopher K Murphy, Ellie Hershberger, Parviz Ghahramani, and A C Stevens. 2024. “Small-Molecule Neutrophil Modulator ADS051 Is Safe and Well-Tolerated in a Phase 1 Single Ascending Dose Study.”. The American Journal of Gastroenterology 120 (7): 1585-92.